PaulMHassounMD

Pulmonology • Baltimore, MD

Critical Care Medicine, Pleural Disease

Professor of Medicine, Johns Hopkins University School of Medicine; Director, Pulmonary Hypertension Program

Join to view full profile

Dr. Hassoun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hassoun's full profile

Already have an account?

Office
600 N Wolfe St
Baltimore, MD 21287
Phone+1 410-955-3467

Education & Training

Tufts Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1988
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1981 - 1984
University of Paris VII Faculty of MedicineClass of 1981

Certifications & Licensure

MD State Medical License 2002 - 2026
MA State Medical License 1983 - 2003
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis Start of enrollment: 2010 Jan 01
Completed
Phase 4
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Completed
Phase 2
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH Start of enrollment: 2019 Apr 15
Recruiting
Join now to see all

Publications & Presentations

PubMed

Alterations in Mitochondrial Function in Pulmonary Vascular Diseases.
Samar Farha, Kewal Asosingh, Paul M Hassoun, John Barnard, Suzy Comhair
Antioxidants & Redox Signaling. 2024-12-10
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk Models.
Megan Griffiths, Catherine E Simpson, Jun Yang, Dhananjay Vaidya, Melanie K Nies
Chest. 2024-12-01
1 citations
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension.
Yogesh N V Reddy, Robert P Frantz, Paul M Hassoun, Anna R Hemnes, Evelyn Horn
Journal of the American College of Cardiology. 2024-11-26

Press Mentions

Pulmonary Arterial Hypertension: Critical Observations in Pulmonary Medicine, Ep. 3April 21st, 2022
The Key Laboratory of Pulmonary Vascular Medicine, Chinese Academy of Medical Sciences (KLPVM-CAMS): A Medical Centre Focusing on Clinical, Translational and Basic Research, Whose Mission Is to Improve the Outcome of Patients with Pulmonary Vascular Di...December 21st, 2019
Pulmonary Vascular Disease Phenomics Program PVDOMICS (PVDOMICS)January 13th, 2017

Other Languages

French, Arabic

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/paul-hassoun